Back in April 2014, shortly after the FDA warned the use of power morcellators during uterine fibroid removal could increase risk of cancer, Johnson & Johnson (J&J), announced that it was suspending sales of these devices pending new information on potential safety concerns. Since then,…
In April 2014, the FDA warned about the cancer risks associated with using power morcellation in uterine fibroid removal and hysterectomy procedures. Since then, many doctors have shied away from the technique, while a number of hospitals have stopped using the devices. Rather than completely…
The Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee will come together on July 10th and 11th of 2014 to discuss the risks and benefits of power morcellation. One of those risks includes the potential for the power morcellator to spread cancerous…
Another Risperdal lawsuit has been filed due to serious side effects. Andrew Wasserman and his mother, Mary Wasserman, filed the complaint on June 12, 2014 against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals (3:14-cv-02739). Andrew allegedly developed breasts requiring a double mas
The FDA has received 22 report of serious adverse reactions, including death, among children and infants 5 months to 3.5 years of age that were given oral viscous lidocaine to treat teething pain. Now, the federal agency is requiring a boxed warning on those products.…
Manufacturers of testosterone therapy products will now include a more general warning on their labels about the risk of blood clots in the veins tied to the use of these drugs. Drug labels on approved testosterone therapy products already warned about the risk of “venous…
Two gynecological organizations, the American College of Obstetricians and Gynecologists (ACOG), and the AAGL, formerly known as the American Association of Gynecologic Laparoscopists, released reports in May 2014 confirming there is no way to unequivocally confirm if a woman has a uterine sarcoma b
Women who have been diagnosed with a serious and sometimes life-threatening cancer because of laparoscopic surgery with a power morcellator are fighting back. A California woman and her husband, for example, recently filed a morcellator lawsuit against Richard Wolf Medical Instruments Corporation. T
On April 17, 2014, the FDA issued a safety communication discouraging physicians from using laparoscopic power morcellation for removing uterine fibroids. Studies and reports have revealed that the procedure creates a slight risk of spreading cancerous tissues beyond the uterus. Now, Health Canada h
In a recent safety communication, the FDA discouraged the use of power morcellators for hysterectomies or the removal of uterine fibroids, because of a concern of cancer risk. Since then, health experts have been debating the pros and cons of this procedure, with many hospitals…
In October 2006, the FDA approved the use of Risperdal (risperidone), an anti-psychotic medication, for the treatment of irritability in autistic children and young adults. Up until then, the drug had been approved only for use in adults, but was still apparently often prescribed off-label…
Following the FDA warning concerning power morcellators in uterine surgery, Intuitive Surgical, makers of the da Vinci robot, cut back on its projection for growth. According to a report in the Wall Street Journal, the technology company had initially expected to see an increase of…
